0001140361-16-082699.txt : 20161013 0001140361-16-082699.hdr.sgml : 20161013 20161013164848 ACCESSION NUMBER: 0001140361-16-082699 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20161011 FILED AS OF DATE: 20161013 DATE AS OF CHANGE: 20161013 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HANGER, INC. CENTRAL INDEX KEY: 0000722723 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093] IRS NUMBER: 840904275 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10910 DOMAIN DRIVE STREET 2: SUITE 300 CITY: AUSTIN STATE: TX ZIP: 78758 BUSINESS PHONE: 512-777-3800 MAIL ADDRESS: STREET 1: 10910 DOMAIN DRIVE STREET 2: SUITE 300 CITY: AUSTIN STATE: TX ZIP: 78758 FORMER COMPANY: FORMER CONFORMED NAME: HANGER ORTHOPEDIC GROUP INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: SEQUEL CORP DATE OF NAME CHANGE: 19890814 FORMER COMPANY: FORMER CONFORMED NAME: CELLTECH COMMUNICATIONS INC DATE OF NAME CHANGE: 19860304 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hartman Thomas E CENTRAL INDEX KEY: 0001466989 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10670 FILM NUMBER: 161935332 MAIL ADDRESS: STREET 1: HANGER ORTHOPEDIC GROUP, INC. STREET 2: TWO BETHESDA METRO CENTER, SUITE 1200 CITY: BETHESDA STATE: MD ZIP: 20814 4 1 doc1.xml FORM 4 X0306 4 2016-10-11 0 0000722723 HANGER, INC. HGR 0001466989 Hartman Thomas E 10910 DOMAIN DRIVE SUITE 300 AUSTIN TX 78758 0 1 0 0 SVP and General Counsel Common Stock 2016-10-11 4 A 0 5000 0 A 30858 D Represents a grant of time-based restricted stock under the Company's 2016 Omnibus Incentive Plan, which vests to the extent of 25% annually beginning on October 11, 2017 and cumulatively vests to the extent of 25% each year thereafter. Consists of (i) unvested restricted shares which total 5,000 shares of stock from an initial grant of 5,000 shares of restricted stock that begins to vest on October 11, 2017; (ii) unvested restricted shares totaling 10,000 shares of stock from an initial grant of 10,000 shares of restricted stock that begins to vest on March 7, 2017; (iii) unvested restricted shares totaling 4,958 shares of stock from an initial grant of 4,958 shares of restricted stock made on November 10, 2015; (iv) unvested restricted shares and fully vested shares totaling 4,239 shares of stock from an initial grant of 4,239 shares of restricted stock made on March 6, 2015; (v) unvested restricted shares and fully vested shares totaling 1,589 shares of stock from an initial grant of 1,731 shares of restricted stock made on March 7, 2014; [continued in next footnote] (vi) unvested restricted shares and fully vested shares totaling 2,219 shares of stock from an initial grant of 3,246 shares of restricted stock and performance made on March 11, 2013; (vii) fully vested shares totaling 2,008 shares from an initial grant of 4,800 shares of restricted stock made on March 7, 2012 and (viii) fully vested shares totaling 845 shares from an initial grant of 4,600 shares of restricted stock made on March 25, 2011 and cumulatively vest to the extent of one-quarter each year thereafter, subject to certain provisions under the Company's 2010 Omnibus Incentive Plan and the Plan, and which shall become fully vested upon a termination of employment not involving termination for cause or voluntary termination. Except as otherwise noted, all remaining unvested restricted shares will continue to vest at a rate of 25% per year of the original grant amount on the anniversary date of the grant. /s/ Jessica Lochmann Allen, Attorney-in-Fact for Thomas E. Hartman 2016-10-13